insurance that covers glp-1 coverage just changed for as many as 56 million Americans when it comes to the popular medications used to promote weight loss. Link in comments ⬇️ My Insurance Won't Cover GLP-1

Cardiovascular Outcomes Data Favors Semaglutide For Now The SELECT trial (published in the New England Journal of Medicine in 2023) demonstrated that semaglutide reduced major adverse cardiovascular events by 20% in patients with obesity and established cardiovascular disease

Jun 2007;177(6):2179-2184

The histidine residues provide a tertiary structural interaction with the two domains of PrP and copper, that is also protective in function due to involvement of the conserved central region of the protein (Roseman et al., 2020)

[PMID: 25207106] PubMed record related to this compound for laboratory literature review

It protects cells from damage and helps regulate melanin formation

To put that in perspective, you'd need massive amounts of oral supplements to come close to these therapeutic doses - and most wouldn't make it to your cells intact